Objective: To evaluate the effects of metformin on the ovarian response to gonadotropins given for in vitro fertilization (IVF) programs in patients with polycystic ovary syndrome (PCOS) and reduced ovarian reserve. Design: Prospective, parallel, randomized, double-blind, placebo-controlled clinical trial. Setting: Academic departments of obstetrics and gynecology, and a private IVF center. Patient(s): Primary infertile patients with PCOS older than 35 years and/or with a basal follicle-stimulating hormone (FSH) level higher than 10 IU/L who were scheduled for IVF cycles. Intervention(s): Gonadotropin-releasing hormone agonist flare-up protocol and high starting doses of recombinant FSH plus metformin or placebo tablets. Main Outcome Measur...
BACKGROUND: Several data have demonstrated the efficacy of metformin in inducing ovulation in patien...
Objective: To evaluate the effects of metformin administration on spontaneous LH episodic release in...
Background: Clomiphene citrate (CC) is generally considered first-line treatment in women with anovu...
OBJECTIVE: To test whether metformin administration reduces the incidence of ovarian hyperstimulatio...
OBJECTIVE: To test whether metformin administration reduces the incidence of ovarian hyperstimulatio...
OBJECTIVE: To test whether metformin administration reduces the incidence of ovarian hyperstimulat...
Objective: To evaluate whether pretreatment with metformin improves FSH- induced ovulation in women ...
The study aim was to evaluate our personal experience regarding the use and the reproductive effect ...
BACKGROUND: Metformin appears to improve reproductive function in some women with polycystic ovary s...
Objective(s): To evaluate the effects of metformin on insulin resistance, ovarian androgen productio...
Background Metformin is widely used for treating women with polycystic ovary syndrome (PCOS), and ma...
STUDY QUESTION: Does ‘metformin’ reduce the incidence of ovarian hyperstimulation syndrome (OHSS) fo...
Background: Metformin, an insulin-sensitizing agent, has been used successfully as the first-line dr...
BackgroundThe use of insulin-sensitising agents, such as metformin, in women with polycystic ovary s...
Background: The significance of polycystic ovarian morphology and its relation to polycystic ovary s...
BACKGROUND: Several data have demonstrated the efficacy of metformin in inducing ovulation in patien...
Objective: To evaluate the effects of metformin administration on spontaneous LH episodic release in...
Background: Clomiphene citrate (CC) is generally considered first-line treatment in women with anovu...
OBJECTIVE: To test whether metformin administration reduces the incidence of ovarian hyperstimulatio...
OBJECTIVE: To test whether metformin administration reduces the incidence of ovarian hyperstimulatio...
OBJECTIVE: To test whether metformin administration reduces the incidence of ovarian hyperstimulat...
Objective: To evaluate whether pretreatment with metformin improves FSH- induced ovulation in women ...
The study aim was to evaluate our personal experience regarding the use and the reproductive effect ...
BACKGROUND: Metformin appears to improve reproductive function in some women with polycystic ovary s...
Objective(s): To evaluate the effects of metformin on insulin resistance, ovarian androgen productio...
Background Metformin is widely used for treating women with polycystic ovary syndrome (PCOS), and ma...
STUDY QUESTION: Does ‘metformin’ reduce the incidence of ovarian hyperstimulation syndrome (OHSS) fo...
Background: Metformin, an insulin-sensitizing agent, has been used successfully as the first-line dr...
BackgroundThe use of insulin-sensitising agents, such as metformin, in women with polycystic ovary s...
Background: The significance of polycystic ovarian morphology and its relation to polycystic ovary s...
BACKGROUND: Several data have demonstrated the efficacy of metformin in inducing ovulation in patien...
Objective: To evaluate the effects of metformin administration on spontaneous LH episodic release in...
Background: Clomiphene citrate (CC) is generally considered first-line treatment in women with anovu...